SCHWARZEROVÁ, Jana, Martin HURTA, Vojtěch BARTOŇ, Matej LEXA, Dirk WALTHER, Valentine PROVAZNÍK and Wolfram WECKWERTH. A perspective on genetic and polygenic risk scores — advances and limitations and overview of associated tools. Briefings in Bioinformatics. Oxford University Press, 2024, vol. 25, No 3, p. bbae240, 11 pp. ISSN 1467-5463. Available from: https://dx.doi.org/10.1093/bib/bbae240.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A perspective on genetic and polygenic risk scores — advances and limitations and overview of associated tools
Authors SCHWARZEROVÁ, Jana, Martin HURTA, Vojtěch BARTOŇ, Matej LEXA, Dirk WALTHER, Valentine PROVAZNÍK and Wolfram WECKWERTH.
Edition Briefings in Bioinformatics, Oxford University Press, 2024, 1467-5463.
Other information
Original language English
Type of outcome Article in a journal
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 9.500 in 2022
Organization unit Faculty of Informatics
Doi http://dx.doi.org/10.1093/bib/bbae240
Keywords in English polygenic risk score; genetic variations; GWAS; genomic prediction; genotype; phenotype
Tags International impact, Reviewed
Changed by Changed by: doc. Ing. Matej Lexa, Ph.D., učo 31298. Changed: 22/5/2024 09:19.
Abstract
Polygenetic Risk Scores are used to evaluate an individual's vulnerability to developing specific diseases or conditions based on their genetic composition, by taking into account numerous genetic variations. This article provides an overview of the concept of Polygenic Risk Scores (PRS). We elucidate the historical advancements of PRS, their advantages and shortcomings in comparison with other predictive methods, and discuss their conceptual limitations in light of the complexity of biological systems. Furthermore, we provide a survey of published tools for computing PRS and associated resources. The various tools and software packages are categorized based on their technical utility for users or prospective developers. Understanding the array of available tools and their limitations is crucial for accurately assessing and predicting disease risks, facilitating early interventions, and guiding personalized healthcare decisions. Additionally, we also identify potential new avenues for future bioinformatic analyzes and advancements related to PRS.
PrintDisplayed: 23/6/2024 06:16